Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial
Addiction · 2026
DOI: 10.1111/add.70385 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2026. Verfasst von Neal L Benowitz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Nicotine, Tobacco Products, Electronic Nicotine Delivery Systems, Smoking Cessation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Drug Abuse and the Food and Drug Administration‧s Center for Tobacco Products, National Institutes of Health‧s National Center for Advancing Translational Sciences, National Cancer Institute Cancer Center Support.
Abstract (Originalsprache)
Background and aims Mandated reduction of the nicotine content of cigarettes to reduce addictiveness to minimal levels has the potential to substantially reduce combusted cigarette use and promote public health. This paper examined the hypothesis that when people who smoke cigarettes are switched to very low nicotine content (VLNC) cigarettes and provided with access to non‐combusted alternative nicotine delivery systems (ANDS), they will titrate nicotine to maintain baseline levels of nicotine intake with the use of ANDS.
Design
This is a secondary analysis of a recently published randomized clinical trial. Clinical trial number NCT03272685.
Setting
Multicenter clinical trial conducted in the United States.
Participants
438 individuals who smoked 5 to 40 cigarettes per day, mean age 44 (range 20–73).
Intervention
Smokers were randomized 1:1 for 12 weeks of smoking Spectrum brand research cigarettes containing VLNC (0.4 mg nicotine/g tobacco) or normal nicotine content (15.8 mg nicotine/g, NNC). Participants purchased tobacco products from an experimental marketplace containing non‐combusted ANDS, including electronic cigarettes, nicotine replacement medications and oral nicotine products.
Measurements
Measures taken at baseline, 4, 8 and 12 weeks included cigarettes smoked per day (CPD) and measures of ANDS use, assessed using past 3‐day daily diary data, which would roughly account for nicotine intake as measured by urine total nicotine equivalents (TNE). Based on self‐report and biomarker data at weeks 4, 8 and 12, we characterized three product‐using groups of participants as cigarette‐only users, ANDS‐only users and dual users. Nicotine titration was assessed as the ratio of urine TNE at various research cigarette study weeks compared with baseline (smoking their own cigarettes). Combusted product abstinence was examined using expired carbon monoxide (CO) and adherence to smoking VLNC by urine anatabine.
Findings
Median titration at 12 weeks in cigarette‐only participants was 0.84 (interquartile range 0.68–1.18) in the NNC group and 0.05 (0.01–0.12) in the VLNC group. Median titration at 12 weeks in ANDS‐only participants was 0.81 (0.69–1.16) in the NNC group and 0.89 (0.49–1.58) in the VLNC group. Median titration at 12 weeks in dual use participants was 1.0 (0.78–1.29) in the NNC group and 0.91 (0.61–1.25) in the VLNC group.
Conclusions
Most adults who smoke, when switched to very low nicotine content cigarettes, will use available alternative nicotine delivery systems (ANDS) to supplement their intake of nicotine. Provision of ANDS appears to be associated with a high degree of nicotine titration. Making less harmful ANDS widely available may make a mandated nicotine reduction intervention more acceptable to people who smoke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, University of California, San Francisco, CA, USA.
- Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
- Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, NC, USA.
- Center for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI, USA.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Neal L Benowitz, Xianghua Luo, Suzanne Colby, Dorothy K Hatsukami
Förderung
- National Institute of Drug Abuse and the Food and Drug Administration‧s Center for Tobacco Products
- National Institutes of Health‧s National Center for Advancing Translational Sciences
- National Cancer Institute Cancer Center Support
Zitieren
APA
Benowitz, N. L., Hu, J., Luo, X., McClernon, F. J., Tidey, J., Strasser, A. A., Colby, S., Donny, E. C., & Hatsukami, D. K. (2026). Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial. Addiction. https://doi.org/10.1111/add.70385
Vancouver
Benowitz NL, Hu J, Luo X, McClernon FJ, Tidey J, Strasser AA, et al. Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial. Addiction. 2026. doi:10.1111/add.70385
BibTeX
@article{Benowitz2026,
author = {Benowitz, Neal L and Hu, Jiayi and Luo, Xianghua and McClernon, F Joseph and Tidey, Jennifer and Strasser, Andrew A and Colby, Suzanne and Donny, Eric C and Hatsukami, Dorothy K},
title = {Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70385}
}
EUVIMED